Library Subscription: Guest
Critical Reviews™ in Oncogenesis

Published 4 issues per year

ISSN Print: 0893-9675

ISSN Online: 2162-6448

SJR: 0.395 SNIP: 0.322 CiteScore™:: 2.5 H-Index: 54

Indexed in

IAPs: Mediators of Oncogenesis and Targets for Anticancer Therapy

Volume 21, Issue 5-6, 2016, pp. 399-411
DOI: 10.1615/CritRevOncog.2017021084
Get accessGet access

ABSTRACT

The inhibitor of apoptosis (IAP) family members are potent regulators of cell homeostasis able to regulate several fundamental cellular processes that include cell death, cell proliferation, cell differentiation, and inflammation. Regarding this broad spectrum of activity, it is now becoming clear that some members of the family possess oncogenic properties. Analysis of genomic database from tumor sequencing studies has revealed a number of genetic alterations affecting some IAP genes and resulting in gain or loss of function. In this review, we discuss the importance of IAP alterations in cell transformation and their link with key oncogenic pathways, focusing on nuclear factor-kappa B (NF-κB)–activating signaling pathways. Then we highlight the therapeutic potential of IAP antagonists and nitric oxide (NO) donors as inhibitors of NF-κB in anticancer therapy.

CITED BY
  1. Mir Seyed Mostafa, Yousefi Bahman, Marjani Abdoljalal, Rahimi Mahdi, Qujeq Durdi, The Sensitization of Melatonin in Osteosarcoma Cells by Suppression of Anti-Apoptotic Proteins, Pharmaceutical Sciences, 26, 2, 2020. Crossref

Begell Digital Portal Begell Digital Library eBooks Journals References & Proceedings Research Collections Prices and Subscription Policies Begell House Contact Us Language English 中文 Русский Português German French Spain